Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Characterizing Mature T-Cell Lymphoma Patients' Outcomes By Race

Miao Cao, Rahul S. Bhansali, Wenrui Li, Qi Long, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Nasta, Jakub Svoboda, Stephen J. Schuster, Stefan K. Barta

Blood (2022) 140 (Supplement 1): 12013–12015.

https://doi.org/10.1182/blood-2022-168032

Published: 2022

Journal Articles

The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies

Blood (2021) 138 (Supplement 1): 253.

https://doi.org/10.1182/blood-2021-153945

Published: 2021

Journal Articles

A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse

Blood (2021) 138 (Supplement 1): 1382.

https://doi.org/10.1182/blood-2021-148868

Published: 2021

Journal Articles

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Blood (2018) 132 (20): 2115–2124.

https://doi.org/10.1182/blood-2018-07-862334

Published: 2018

Includes: Supplemental data

Journal Articles

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Blood (2017) 129 (12): 1646–1657.

https://doi.org/10.1182/blood-2016-10-746933

Published: 2017

Journal Articles

Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia

Anthony R. Mato, Prioty Islam, Catherine Daniel, Lauren Strelec, Adam H. Kaye, Sarah Brooks, Alex Ganetsky, Sunita Nasta, David L. Porter, Jakub Svoboda, Chadi Nabhan, Stephen J. Schuster

Blood (2016) 127 (8): 1064–1067.

https://doi.org/10.1182/blood-2015-12-686873

Published: 2016

Journal Articles

Reduced Intensity Conditioning with Fludarabine/Busulfan 6.4mg/Kg Results In High Donor Chimerism and Low Toxicity In Both Related and Unrelated Allo-SCT for Hematologic Malignancies.

Steven C Goldstein, MD, Selina M. Luger, MD, Noelle Frey, MD, Alexander Perl, MD, Edward A Stadtmauer, MD, Donald Tsai, MD, Alison Loren, MD, Sunita Nasta, MD, Elizabeth Hexner, MD, Ran Reshef, MD, Jacqueline Smith, CRNP, Joanne Hinkle, Pavel Vassilev, BS, Michael J Vozniak, PharmD, David L. Porter, MD

Blood (2010) 116 (21): 4519.

https://doi.org/10.1182/blood.V116.21.4519.4519

Published: 2010

Journal Articles

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

Julie H. Lin, Ellen J. Kim, Anand Bansal, John Seykora, Stephen K. Richardson, Xian-Yuan Cha, Sarosh Zafar, Sunita Nasta, Maria Wysocka, Bernice Benoit, Alain H. Rook, Steven S. Fakharzadeh

Blood (2008) 112 (6): 2484–2488.

https://doi.org/10.1182/blood-2008-03-141424

Published: 2008

Journal Articles

A Prospective Clinical Trial of a Novel Epstein-Barr Virus (EBV) PCR Panel in Patients with EBV Associated Malignancies.

Marin F. Xavier, MD, Dale Frank, MD, Sunita Nasta, MD, Stephen Schuster, MD, Charalambos Andreadis, MD, Sharon Arnoldi, Eric Sherman, MD, Sigrid Berg, MD, Anthony Mato, MD, Benjamin Musher, MD, Lisa Downs, David Porter, MD, Edward Stadtmauer, MD, Steven Goldstein, MD, Ellen Kim, MD, Donald Tsai, MD

Blood (2007) 110 (11): 2628.

https://doi.org/10.1182/blood.V110.11.2628.2628

Published: 2007

Journal Articles

Adoptive Immunotherapy with Autologous CD25-Depleted and CD3/CD28-Costimulated T-Cells (ACTC) Enhances Numeric and Functional Lymphocyte Recovery after Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma.

Stephen J. Schuster, MD, Bruce L. Levine, PhD, Sunita Nasta, MD, Charalambos Andreadis, MD, Anthony R. Mato, MD, Nicole Aqui, MD, Julio Cotte, Zhaohui Zheng, MS, Andrea Cannon, Benjamin Musher, MD, Bridget Fonash, RN, BSN, Lisa H. Downs, CRNP, Elizabeth Veloso, RN, JD, Carl H. June, MD

Blood (2007) 110 (11): 126.

https://doi.org/10.1182/blood.V110.11.126.126

Published: 2007

Journal Articles

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

David L. Porter, Bruce L. Levine, Nancy Bunin, Edward A. Stadtmauer, Selina M. Luger, Steven Goldstein, Alison Loren, Julie Phillips, Sunita Nasta, Alexander Perl, Steven Schuster, Donald Tsai, Ambika Sohal, Elizabeth Veloso, Stephen Emerson, Carl H. June

Blood (2006) 107 (4): 1325–1331.

https://doi.org/10.1182/blood-2005-08-3373

Published: 2006

Journal Articles

Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Jakub Svoboda, Rebecca Elstrom, Elise A. Chong, Charalambos Andreadis, Arnold Berkowitz, Selina M. Luger, David L. Porter, Sunita Nasta, Lisa H. Downs, Donald L. Siegel, Eli Glatstein, Abass Alavi, Edward A. Stadtmauer, Stephen J. Schuster

Blood (2005) 106 (11): 2090.

https://doi.org/10.1182/blood.V106.11.2090.2090

Published: 2005

Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Rebecca L. Olin, MD, David L. Porter, MD, Selina M. Luger, MD, Stephen J. Schuster, MD, Donald Tsai, MD, PhD, Sunita Nasta, MD, Alexander Perl, MD, Alison W. Loren, MD, Steven Goldstein, MD, Eli Glatstein, MD, Donald L. Siegel, MD, PhD, Dan T. Vogl, MD, Patricia Mangan, CRNP, Kathleen Cunningham, RN, BSN, Edward A. Stadtmauer, MD

Blood (2005) 106 (11): 1170.

https://doi.org/10.1182/blood.V106.11.1170.1170

Published: 2005

Journal Articles

Non-Myeloablative Conditioning with Allogeneic Progenitor Cell Transplantation for Relapsed Hodgkin’s Lymphoma: High Response Rate Despite Prior Chemoresistance.

Steven C. Goldstein, MD, Selina M. Luger, MD, Edward Stadtmauer, MD, Stephen Schuster, MD, Donald Tsai, MD, PhD, Sunita Nasta, MD, Alison Loren, MD, Alexander Perl, MD, Greg Orloff, MD, Julie Oliver, CRNP, Robert Sachs, Stephen Emerson, MD, PhD, David L. Porter, MD.

Blood (2004) 104 (11): 2258.

https://doi.org/10.1182/blood.V104.11.2258.2258

Published: 2004

Journal Articles

Utility of Prophylactic Autologous Stem Cell Collection for Patients with Acute Myeloid Leukemia in First Remission.

Margie Kasner, MD, Selina Luger, MD, Edward Stadtmauer, MD, Stephen Schuster, MD, Donald Tsai, MD, Sunita Nasta, MD, Alexander Perl, MD, Alison Loren, MD, Steven Goldstein, MD, Patricia Mangan, CRNP, Robert Sachs, Donald Seigel, MD, David Porter, MD

Blood (2004) 104 (11): 1872.

https://doi.org/10.1182/blood.V104.11.1872.1872

Published: 2004

Journal Articles

Age and Response after Autologous Stem Cell Transplantation (ASCT) Define a Group of Long-Term Event-Free Survivors among Patients (Pts) with Low-Grade Follicular Lymphoma (FL): A Single Institution Experience.

Charalambos Andreadis, MD, Elise A. Chong, Edward A. Stadtmauer, MD, Selina M. Luger, MD, David L. Porter, MD, Donald Tsai, MD, PhD, Sunita Nasta, MD, Rebecca Elstrom, MD, Steven Goldstein, MD, Lisa Downs, RN, Kathleen Cunningham, Kimberly Hummel, Stephen J. Schuster, MD

Blood (2004) 104 (11): 1883.

https://doi.org/10.1182/blood.V104.11.1883.1883

Published: 2004

Journal Articles

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma Patients with High Risk of Bone Marrow Involvement.

Elise A. Chong, Charalambos Andreadis, MD, Stephen J. Schuster, MD, Selina M. Luger, MD, David L. Porter, MD, Sunita Nasta, MD, Rebecca Elstrom, MD, Steven Goldstein, MD, Robert Sachs, MT, Lisa Downs, CRNP, Joel Green, Patricia A. Mangan, CRNP, Kimberly A. Hummel, Edward A. Stadtmauer, MD

Blood (2004) 104 (11): 5234.

https://doi.org/10.1182/blood.V104.11.5234.5234

Published: 2004

Journal Articles

Pegfilgrastim Versus Filgrastim To Accelerate Hematopoietic Recovery after High Dose Melphalan and Autologous Hematopoietic Stem Cell Transplant (ASCT) for Multiple Myeloma.

Rebecca L. Olin, MD, Selina M. Luger, MD, David L. Porter, MD, Stephen J. Schuster, MD, Donald Tsai, MD, Phd, Sunita Nasta, MD, Alexander Perl, MD, Alison W. Loren, MD, Steven Goldstein, MD, Patricia Mangan, CRNP, Vicki Sherry, CRNP, Kathleen Cunningham, RN, Bob Sachs, Kim Hummel, Edward A. Stadtmauer, MD

Blood (2004) 104 (11): 5193.

https://doi.org/10.1182/blood.V104.11.5193.5193

Published: 2004

Journal Articles

A Predictive Model for Tumor Lysis Syndrome in Acute Myelogenous Leukemia.

Anthony R. Mato, MD, Brett E. Riccio, MD, Li Qin, PhD, Daniel Heitjan, PhD, Alison Loren, MD, Martin Carroll, MD, David Porter, MD, Donald Tsai, MD, Edward Stadtmauer, MD, Sasha Perl, MD, Alan Gewirtz, MD, Sunita Nasta, MD, Stephen Schuster, MD, Steven Goldstein, MD, Selina M. Luger, MD

Blood (2004) 104 (11): 883.

https://doi.org/10.1182/blood.V104.11.883.883

Published: 2004

Journal Articles

Enhancing Graft-vs-Tumor (GVT) Activity of Donor Leukocyte Infusions by Ex-Vivo Expansion and Activation with CD3/CD28 Co-Stimulation.

David Porter, MD, Bruce Levine, PhD, Nancy Bunin, MD, Edward Stadtmauer, MD, Selina Luger, MD, Steven Goldstein, MD, Stephen Schuster, MD, Donald Tsai, MD, Sunita Nasta, MD, Alison Loren, MD, Alexander Perl, MD, Julie Oliver, CRNP, Ambika Sohal, Liz Veloso, RN, Stephen Emerson, MD, PhD, Carl June, MD

Blood (2004) 104 (11): 1640.

https://doi.org/10.1182/blood.V104.11.1640.1640

Published: 2004

NARROW

Characterizing Mature T-Cell Lymphoma Patients' Outcomes By Race

The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies

A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia

Reduced Intensity Conditioning with Fludarabine/Busulfan 6.4mg/Kg Results In High Donor Chimerism and Low Toxicity In Both Related and Unrelated Allo-SCT for Hematologic Malignancies.

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

A Prospective Clinical Trial of a Novel Epstein-Barr Virus (EBV) PCR Panel in Patients with EBV Associated Malignancies.

Adoptive Immunotherapy with Autologous CD25-Depleted and CD3/CD28-Costimulated T-Cells (ACTC) Enhances Numeric and Functional Lymphocyte Recovery after Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma.

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Non-Myeloablative Conditioning with Allogeneic Progenitor Cell Transplantation for Relapsed Hodgkin’s Lymphoma: High Response Rate Despite Prior Chemoresistance.

Utility of Prophylactic Autologous Stem Cell Collection for Patients with Acute Myeloid Leukemia in First Remission.

Age and Response after Autologous Stem Cell Transplantation (ASCT) Define a Group of Long-Term Event-Free Survivors among Patients (Pts) with Low-Grade Follicular Lymphoma (FL): A Single Institution Experience.

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma Patients with High Risk of Bone Marrow Involvement.

Pegfilgrastim Versus Filgrastim To Accelerate Hematopoietic Recovery after High Dose Melphalan and Autologous Hematopoietic Stem Cell Transplant (ASCT) for Multiple Myeloma.

A Predictive Model for Tumor Lysis Syndrome in Acute Myelogenous Leukemia.

Enhancing Graft-vs-Tumor (GVT) Activity of Donor Leukocyte Infusions by Ex-Vivo Expansion and Activation with CD3/CD28 Co-Stimulation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only